Reply to: Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)

por López-Mendez, Ivan, Castro-Narro, Graciela
Publicado 2021

Bariatric endoscopic-surgical therapies for NAFLD. Should they be considered viable options among current treatments?

por Juárez-Hernández, Eva, Velázquez-Alemán, Alain P., Castro-Narro, Graciela, Uribe, Misael, López-Méndez, Iván
Publicado 2022

Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)

por Lopez-Mendez, Ivan, Aquino-Matus, Jorge, Gall, Sofia Murua-Beltrán, Prieto-Nava, Jose D., Juarez-Hernandez, Eva, Uribe, Misael, Castro-Narro, Graciela
Publicado 2021

Impact on Prevalence of the Application of NAFLD/MAFLD Criteria in Overweight and Normal Weight Patients

por Ordoñez-Vázquez, Ana Luisa, Juárez-Hernández, Eva, Zuarth-Vázquez, Julia María, Ramos-Ostos, Martha Helena, Uribe, Misael, Castro-Narro, Graciela, López-Méndez, Iván
Publicado 2022

Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection

por Mendizabal, Manuel, Ridruejo, Ezequiel, Piñero, Federico, Anders, Margarita, Padilla, Martín, Toro, Luis G., Torre, Aldo, Montes, Pedro, Urzúa, Alvaro, Gonzalez Ballerga, Esteban, Silveyra, María Dolores, Michelato, Douglas, Díaz, Javier, Peralta, Mirta, Pages, Josefina, García, Sandro Ruiz, Gutierrez Lozano, Isabel, Macias, Yuridia, Cocozzella, Daniel, Chavez-Tapia, Norberto, Tagle, Martín, Dominguez, Alejandra, Varón, Adriana, Vera Pozo, Emilia, Higuera-de la Tijera, Fátima, Bustios, Carla, Conte, Damián, Escajadillo, Nataly, Gómez, Andrés J, Tenorio, Laura, Castillo Barradas, Mauricio, Schinoni, Maria Isabel, Bessone, Fernando, Contreras, Fernando, Nazal, Leyla, Sanchez, Abel, García, Matías, Brutti, Julia, Cabrera, María Cecilia, Miranda-Zazueta, Godolfino, Rojas, German, Cattaneo, Maximo, Castro-Narro, Graciela, Rubinstein, Fernando, Silva, Marcelo O.
Publicado 2021

P-13 COMPARISON OFF DIFFERENT PROGNOSTIC SCORES FOR PATIENTS WITH CIRRHOSIS HOSPITALIZED WITH SARS – COV 2 INFECTION

por Mendizabal, Manuel, Ridruejo, Ezequiel, Piñero, Federico, Anders, Margarita, Padilla, Martín, Toro, Luis G., Torre, Aldo, Montes, Pedro, Urzúa, Alvaro, Gonzalez Ballerga, Esteban, Silveyra, María Dolores, Michelato, Douglas, Díaz, Javier, Peralta, Mirta, Pages, Josefina, Ruiz García, Sandro, Gutierrez Lozano, Isabel, Macias, Yuridia, Cocozzella, Daniel, Chavez-Tapia, Norberto, Tagle, Martín, Dominguez, Alejandra, Varón, Adriana, Vera Pozo, Emilia, Higuera-de la Tijera, Fátima, Bustios, Carla, Conte, Damiá, Escajadillo, Nataly, Gómez, Andrés J, Tenorio, Laura, Castillo Barradas, Mauricio, Schinoni, Maria Isabel, Bessone, Fernando, Contreras, Fernando, Nazal, Leyla, Sanchez, Abel, García, Matías, Brutti, Julia, Cabrera, María Cecilia, Miranda-Zazueta, Godolfino, Rojas, German, Cattaneo, Maximo, Castro-Narro, Graciela, Rubinstein, Fernando, Silva, Marcelo O.
Publicado 2021

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

por Rinella, Mary E., Lazarus, Jeffrey V., Ratziu, Vlad, Francque, Sven M., Sanyal, Arun J., Kanwal, Fasiha, Romero, Diana, Abdelmalek, Manal F., Anstee, Quentin M., Arab, Juan Pablo, Arrese, Marco, Bataller, Ramon, Beuers, Ulrich, Boursier, Jerome, Bugianesi, Elisabetta, Byrne, Christopher D., Castro Narro, Graciela E., Chowdhury, Abhijit, Cortez-Pinto, Helena, Cryer, Donna R., Cusi, Kenneth, El-Kassas, Mohamed, Klein, Samuel, Eskridge, Wayne, Fan, Jiangao, Gawrieh, Samer, Guy, Cynthia D., Harrison, Stephen A., Kim, Seung Up, Koot, Bart G., Korenjak, Marko, Kowdley, Kris V., Lacaille, Florence, Loomba, Rohit, Mitchell-Thain, Robert, Morgan, Timothy R., Powell, Elisabeth E., Roden, Michael, Romero-Gómez, Manuel, Silva, Marcelo, Singh, Shivaram Prasad, Sookoian, Silvia C., Spearman, C. Wendy, Tiniakos, Dina, Valenti, Luca, Vos, Miriam B., Wong, Vincent Wai-Sun, Xanthakos, Stavra, Yilmaz, Yusuf, Younossi, Zobair, Hobbs, Ansley, Villota-Rivas, Marcela, Newsome, Philip N.
Publicado 2023